"AIDS Treatment News" online - New Issue #304 (searchable/indexed)

Immunet / AIDS Treatment News atn at immunet.org
Tue Oct 13 16:50:01 EST 1998

Immunet / AIDS-dot-ORG

The latest issue of AIDS Treatment News (#304) has been added
to the complete AIDS Treatment News archive on Immunet / AIDS-dot-ORG
at http://www.immunet.org or http://www.aids.org


--- New issue features:

  * Efavirenz (SUSTIVA(TM)) Approved
  * Crixivan(R) (Indinavir): Three Doses Daily,Not Two,in Most Regimens
  * Amprenavir (Agenerase(TM)) Now Available in Expanded Access
  * Successful Standard Treatment for Lipid Abnormalities:
      -- Experience with 44 Patients
  * San Francisco: Body Shape Changes and Lipodystrophy--
      -- Community Forum October 19
  * ICAAC Conference: Daily Summaries Available
  * Abacavir (Ziagen(TM)) Advisory Committee Meeting, November 2
  * Prison Treatment Programs: Glaxo-Wellcome Awards 19 Grants
  * Iscador Update: Interview with Robert Gorter, M.D.
  * United States Conference on AIDS, Dallas, Oct. 29 - Nov. 1
  * San Francisco: POZ Life Expo, October 16-17


You can read this and every previous issue of AIDS Treatment News
at http://www.immunet.org or http://www.aids.org.
The Immunet/AIDS-dot-ORG site features a sophisticated search engine
to simplify access to over 12 years of AIDS Treatment News articles.
Also featured is John S. James' helpful personal index.

***  About AIDS TREATMENT NEWS  ***                 

AIDS TREATMENT NEWS is one of the primary treatment resources
for AIDS and HIV.  It reports on experimental and standard
treatments, especially those available now, and has been
published twice monthly, continuously since 1986 by John S. James.

AIDS TREATMENT NEWS interviews physicians, scientists, other
health professionals, and persons with AIDS or HIV.  They also
collect information from meetings and conferences, medical
journals, and computer databases. Long-term survivors have
usually tried many different treatments, and found combinations
which work for them.  AIDS TREATMENT NEWS does not recommend
particular therapies, but seeks to increase the options available.

AIDS TREATMENT NEWS is funded by subscriptions and contributions
and does not accept contributions from pharmaceutical companies
or others whose products they might cover.

* Immunet / AIDS-dot-ORG  - a non profit AIDS Service Organization
* http://www.immunet.org
* http://www.aids.org
* info at immunet.org

More information about the Bioforum mailing list